Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation

Intravitreal ranibizumab therapy is widely used in treatment of subfoveal choroidal neovascularisation (CNV) in age-related macular degeneration. We wanted to study the effect of intravitreal ranibizumab therapy in peripapillary CNV. A prospective recording of treatment outcomes in twelve eyes (12 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamoudi, Hassan, Sørensen, Torben Lykke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253451/
https://www.ncbi.nlm.nih.gov/pubmed/22235362
http://dx.doi.org/10.1155/2011/602729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253451/
https://www.ncbi.nlm.nih.gov/pubmed/22235362
http://dx.doi.org/10.1155/2011/602729

Ejemplares similares